APA (7th ed.) Citation

Yilun Li, Yilun Li, Yilun Li, Xiaolu Yang, Xiaolu Yang, Li Ma, & Li Ma. (2024). Comparative analysis of adverse event risks in breast cancer patients receiving pembrolizumab combined with paclitaxel versus paclitaxel monotherapy: Insights from the FAERS database. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yilun Li, Yilun Li, Yilun Li, Xiaolu Yang, Xiaolu Yang, Li Ma, and Li Ma. Comparative Analysis of Adverse Event Risks in Breast Cancer Patients Receiving Pembrolizumab Combined with Paclitaxel Versus Paclitaxel Monotherapy: Insights from the FAERS Database. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Yilun Li, et al. Comparative Analysis of Adverse Event Risks in Breast Cancer Patients Receiving Pembrolizumab Combined with Paclitaxel Versus Paclitaxel Monotherapy: Insights from the FAERS Database. Frontiers Media S.A., 2024.